This DRP2 phosphorylation regulation has been a target for therapeutic intervention, with treatments that regulate the Akt–GSK-3β–DRP2 signalling pathway in cerebral ischemia [43,48,49]. The gene discussed is GSK3B; the disease is brain ischemia.